The strong expression of CD56 and Ki-67 and the weak expression of CD16 CD57, KIR, CD7 and CD8 were useful to differentiate ANKL from CLPD-NK in this study. This evidence concerns the gene KIR3DL1 and aggressive NK-cell leukemia.